CH228551A - Process for the preparation of p-aminobenzenesulfonyl- (a-aminopyridyl) -methylene sulfonic acid hexamethylenetetramine. - Google Patents

Process for the preparation of p-aminobenzenesulfonyl- (a-aminopyridyl) -methylene sulfonic acid hexamethylenetetramine.

Info

Publication number
CH228551A
CH228551A CH228551DA CH228551A CH 228551 A CH228551 A CH 228551A CH 228551D A CH228551D A CH 228551DA CH 228551 A CH228551 A CH 228551A
Authority
CH
Switzerland
Prior art keywords
aminobenzenesulfonyl
aminopyridyl
sulfonic acid
preparation
hexamethylenetetramine
Prior art date
Application number
Other languages
German (de)
Inventor
Dr. A. Wander A G.
Original Assignee
Wander Ag Dr A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wander Ag Dr A filed Critical Wander Ag Dr A
Publication of CH228551A publication Critical patent/CH228551A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/44Oxygen and nitrogen or sulfur and nitrogen atoms
    • C07D231/46Oxygen atom in position 3 or 5 and nitrogen atom in position 4
    • C07D231/48Oxygen atom in position 3 or 5 and nitrogen atom in position 4 with hydrocarbon radicals attached to said nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

       

  Verfahren zur Darstellung von     p-aminobenzolsulfonyl-(a-aminopyridyl)-          methylensulfosaurem        Hexamethylentetramin.       Es ist bereits bekannt, dass man durch  Einwirkung von     Formaldehydnatriumbisulfit     auf     p-Aminobenzolsulfonyl-a-aminopyridin    das       p-aminobenzolsulfonyl    - (a -     aminopyridyl)    -     me-          thylensulfosaure    Natrium erhält. Aus diesem  kann auf einfache Weise, nämlich durch  Ansäuern mit anorganischen Säuren, die freie       Sulfosäure    der Formel  
EMI0001.0011     
    in kristallinischer Form isoliert werden.

   Ihr  Schmelzpunkt beträgt 184-186  .  



  Es wurde nun gefunden, dass eine Reihe  von Salzen dieser Säure hohen therapeutischen  Wert besitzt und sich zum Teil durch gute  Wasserlöslichkeit auszeichnet, und dass man  diese     Salze    erhält, wenn man die     genannte     Säure mit organischen Basen umsetzt. Als  organische Basen können z.

   B. folgende ver  wendet werden:     aliphatische    oder aromatische  ein- oder mehrwertige Amine,     Hexamethylen-          tetramin,        aliphatische    oder aromatische     Car-          bonsäureamide,        Pyrazolone,        Pyridine,    Thia-         zole,        Chinoline    oder     Isochinoline,        Azine,          Purine,        Oxazine,        Thiazine,

      basische     Acridin-          oder        Azofarbstoffe,    oder Alkaloide. Die so  erhaltenen, bisher noch nicht beschriebenen  Salze sollen als     Therapeutica    Verwendung  finden.  



  Gegenstand des     vorliegenden    Patentes ist  ein Verfahren zur Herstellung des p-amino       benzolsulfonyl-(a-aminopyridyll-methylensulfo-          sauren        Hexamethylentetramins,    welches da  durch gekennzeichnet ist, dass man auf     p-Ami-          nobenzolsulfonyl-    (a -     aminopyridyl)        -methylen-          sulfosäure    der Formel  
EMI0001.0042     
         Hexamethylentetramin    einwirken lässt.

    <I>Beispiel:</I>  68<B>)</B>6 g     p-Aminobenzolsulfonyl-(a-amino-          pyridyl)-methylensulfosäure    der Formel  
EMI0001.0046     
    werden in 200     cm'        Alkohol    aufgeschwemmt      und mit einer Lösung von 24 g     Hexamethylen-          tetramin    in 400 cm' Wasser geschüttelt,       gegebenenfalls    unter Anwendung von geringer  Wärme.

   Nach kurzer Zeit kristallisiert das       p-aminobenzolsulfonyl    - (a -     aminopyridyl)    -     me-          thylensulfosaure        Hexamethylentetramin    in  weissen silberglänzenden Schuppen. Das Salz  kann aus einem geeigneten Lösungsmittel.  umkristallisiert werden; es ist leicht wasser  löslich und hat den Schmelzpunkt     170-1711'.  



  Process for the preparation of p-aminobenzenesulfonyl- (a-aminopyridyl) -methylene sulfonic acid hexamethylenetetramine. It is already known that the action of sodium formaldehyde bisulfite on p-aminobenzenesulfonyl-a-aminopyridine gives p-aminobenzenesulfonyl- (a-aminopyridyl) -methylenesulfonic acid sodium. From this, in a simple manner, namely by acidification with inorganic acids, the free sulfonic acid of the formula
EMI0001.0011
    can be isolated in crystalline form.

   Their melting point is 184-186.



  It has now been found that a number of salts of this acid have a high therapeutic value and are in some cases characterized by good solubility in water, and that these salts are obtained when the acid mentioned is reacted with organic bases. As organic bases, for.

   B. the following are used: aliphatic or aromatic mono- or polyvalent amines, hexamethylene tetramine, aliphatic or aromatic carboxamides, pyrazolones, pyridines, thiazoles, quinolines or isoquinolines, azines, purines, oxazines, thiazines,

      basic acridine or azo dyes, or alkaloids. The salts obtained in this way, not yet described, are intended to be used as therapeutic agents.



  The subject of the present patent is a process for the preparation of p-amino benzenesulfonyl- (a-aminopyridyll-methylene-sulfo-acidic hexamethylenetetramine, which is characterized in that p-aminobenzenesulfonyl- (a - aminopyridyl) -methylene sulfonic acid is used formula
EMI0001.0042
         Let hexamethylenetetramine act.

    <I> Example: </I> 68 <B>) </B> 6 g of p-aminobenzenesulfonyl- (a-aminopyridyl) -methylene sulfonic acid of the formula
EMI0001.0046
    are suspended in 200 cm 'of alcohol and shaken with a solution of 24 g of hexamethylene tetramine in 400 cm' of water, optionally using low heat.

   After a short time, the p-aminobenzenesulfonyl - (a - aminopyridyl) - methylene sulfonic acid hexamethylenetetramine crystallizes in white, silvery scales. The salt can be obtained from a suitable solvent. be recrystallized; it is easily soluble in water and has a melting point of 170-1711 '.


    

Claims (1)

PATENTANSPRUCH: Verfahren zur Herstellung von p-amino- benzols ulfonyl-(a-aminopyridyl)-methylensulfo- saurem Hexamethylentetramin, dadurch ge kennzeichnet, dass man auf p-Aminobenzolsulfo- nyl (a-äminopyriclyl)-methylensulfosäure der Formel EMI0002.0017 Hexamethylentetramin einwirken lässt. Das erhaltene neue Produkt kristallisiert in weissen, silberglänzenden Schuppen vom Schmelzpunkt 170 -171'). Es ist leicht was serlöslich und soll fürtherapeutische Zwecke verwendet werden. PATENT CLAIM: A process for the preparation of p-aminobenzenesulfonyl- (a-aminopyridyl) -methylenesulfo- acidic hexamethylenetetramine, characterized in that p-aminobenzenesulfonyl (a-aminopyriclyl) -methylene sulfonic acid of the formula EMI0002.0017 Let hexamethylenetetramine act. The new product obtained crystallizes in white, shiny silver flakes with a melting point of 170-171 '). It is easily soluble in water and should be used for therapeutic purposes. UNTERANSPRUCH: Verfahren nach Patentanspruch, dadurch gekennzeichnet, dass man in Gegenwart eines Lösungsmittels arbeitet. SUBCLAIM: Process according to claim, characterized in that one works in the presence of a solvent.
CH228551D 1943-04-06 1942-05-02 Process for the preparation of p-aminobenzenesulfonyl- (a-aminopyridyl) -methylene sulfonic acid hexamethylenetetramine. CH228551A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH228551T 1943-04-06

Publications (1)

Publication Number Publication Date
CH228551A true CH228551A (en) 1943-08-31

Family

ID=4455626

Family Applications (1)

Application Number Title Priority Date Filing Date
CH228551D CH228551A (en) 1943-04-06 1942-05-02 Process for the preparation of p-aminobenzenesulfonyl- (a-aminopyridyl) -methylene sulfonic acid hexamethylenetetramine.

Country Status (1)

Country Link
CH (1) CH228551A (en)

Similar Documents

Publication Publication Date Title
DE905738C (en) Process for the preparation of basic thymoldimethylaminoethyl ethers
CH228551A (en) Process for the preparation of p-aminobenzenesulfonyl- (a-aminopyridyl) -methylene sulfonic acid hexamethylenetetramine.
DE532397C (en) Process for the preparation of polycyclic bases
AT229496B (en) Process for the preparation of the new nicotinic acid ester of dihydroxycodeinone
AT117213B (en) Process for the preparation of poorly soluble salts of organic bases and of alkaloids.
DE578312C (en) Process for the preparation of asymmetric arsenic compounds
DE397813C (en) Process for the preparation of p-dialkylaminoarylphosphinic acids
DE357753C (en) Process for the preparation of a quinine derivative
DE663586C (en) Process for the preparation of novel derivatives of 8-oxyquinoline
CH312531A (en) Process for making a pyridazone.
DE870844C (en) Process for the preparation of soluble salts of p-aminobenzenesulfonylthiourea
DE535956C (en) Process for the preparation of polycyclic bases
DE544087C (en) Process for the preparation of aromatic N-dialkylaminoalkylaminoaldehydes and their derivatives
DE510431C (en) Process for the preparation of nitro compounds of the quinoline series
DE430548C (en) Process for the production of solid, permanent, water-soluble coagulations of dyes from the vat
CH237503A (en) Process for the preparation of 4-amino-benzene-sulfonylaminomethanesulfonic acid.
DE494446C (en) Process for the preparation of acidic wool dyes
DE876999C (en) Process for the production of pellets of 4-aminobenzenesulfonamide
AT124275B (en) Process for the preparation of basic nitro derivatives of 9-aminoacridine.
DE859154C (en) Process for the preparation of Schiff bases of p-aminosalicylic acid
AT200581B (en) Process for the production of new guanidine compounds
AT136393B (en) Method of making a weed killer.
DE511303C (en) Process for the preparation of disodium salts of 4-iminomethylene-sulfuric acid-2-metal-mercaptobenzene-1-sulphonic acid
DE589638C (en) Process for the preparation of 1íñ4-diaminoanthraquinone-2íñ3íñ? -Trisulfonic acids
AT157797B (en) Process for the preparation of aqueous quinidine salt solutions.